{"address1": "777 Old Saw Mill River Road", "city": "Tarrytown", "state": "NY", "zip": "10591-6707", "country": "United States", "phone": "914 847 7000", "website": "https://www.regeneron.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat neovascular age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.", "fullTimeEmployees": 11851, "companyOfficers": [{"maxAge": 1, "name": "Dr. Leonard S. Schleifer M.D., Ph.D.", "age": 69, "title": "Co-Founder, Pres, CEO & Director", "yearBorn": 1953, "fiscalYear": 2022, "totalPay": 7004069, "exercisedValue": 0, "unexercisedValue": 256815824}, {"maxAge": 1, "name": "Dr. George D. Yancopoulos M.D., Ph.D.", "age": 62, "title": "Co-Founder, Pres, Chief Scientific Officer & Director", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 6593696, "exercisedValue": 0, "unexercisedValue": 242710064}, {"maxAge": 1, "name": "Mr. Robert E. Landry Jr.", "age": 58, "title": "Exec. VP of Fin. & CFO", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": 1839460, "exercisedValue": 11097488, "unexercisedValue": 25114408}, {"maxAge": 1, "name": "Dr. Andrew J. Murphy Ph.D.", "age": 63, "title": "Exec. VP of Research", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": 1622950, "exercisedValue": 19388300, "unexercisedValue": 83458888}, {"maxAge": 1, "name": "Mr. Daniel P. Van Plew", "age": 49, "title": "Exec. VP and GM of Industrial Operations & Product Supply", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": 1954399, "exercisedValue": 45282380, "unexercisedValue": 24788798}, {"maxAge": 1, "name": "Ms. Marion E. McCourt", "age": 62, "title": "Exec. VP of Commercial", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 1500262, "exercisedValue": 4246309, "unexercisedValue": 8790830}, {"maxAge": 1, "name": "Ms. Patrice  Gilooly", "title": "Sr. VP of Quality Assurance & Operations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher R. Fenimore", "age": 51, "title": "Sr. VP, Head of Accounting & Controller", "yearBorn": 1971, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gerald  Underwood", "title": "Sr. VP of Technical Operations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bob  McCowan", "title": "Sr. VP of IT & Chief Information Officer", "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 9, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 754.88, "open": 756.36, "dayLow": 746.45, "dayHigh": 756.36, "regularMarketPreviousClose": 754.88, "regularMarketOpen": 756.36, "regularMarketDayLow": 746.45, "regularMarketDayHigh": 756.36, "payoutRatio": 0.0, "trailingPE": 20.661247, "forwardPE": 17.036137, "volume": 432510, "regularMarketVolume": 432510, "averageVolume": 574710, "averageVolume10days": 636970, "averageDailyVolume10Day": 636970, "bid": 745.32, "ask": 752.0, "bidSize": 800, "askSize": 800, "marketCap": 82237521920, "fiftyTwoWeekLow": 538.01, "fiftyTwoWeekHigh": 837.55, "fiftyDayAverage": 789.7928, "twoHundredDayAverage": 726.8708, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 81335525376, "profitMargins": 0.0, "sharesOutstanding": 107507000, "sharesShort": 1213046, "sharesShortPriorMonth": 1213603, "sharesShortPreviousMonthDate": 1678838400, "dateShortInterest": 1681430400, "sharesPercentSharesOut": 0.0111, "heldPercentInsiders": 0.025409998, "heldPercentInstitutions": 0.8964, "shortRatio": 1.93, "shortPercentOfFloat": 0.013200001, "bookValue": 211.813, "priceToBook": 3.5389235, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1680220800, "trailingEps": 36.28, "forwardEps": 44.0, "pegRatio": 6.46, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "REGN", "underlyingSymbol": "REGN", "shortName": "Regeneron Pharmaceuticals, Inc.", "longName": "Regeneron Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 670602600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "e55aa808-7510-354a-9528-01782e66194d", "gmtOffSetMilliseconds": -14400000, "currentPrice": 749.59, "targetHighPrice": 1050.0, "targetLowPrice": 650.0, "targetMeanPrice": 888.3, "targetMedianPrice": 895.0, "recommendationMean": 2.1, "recommendationKey": "buy", "numberOfAnalystOpinions": 23, "revenuePerShare": 113.659, "grossProfits": 7020000000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "trailingPegRatio": 3.1961}